GI Innovation allergic diseases treatment
Scope
Date
~
-
Bio & Pharma
NeoImmuneTech, US think tank to develop treatment for acute radiation syndrome
Biopharmaceutical company NeoImmuneTech has grabbed an opportunity to supply new drug candidates in development as strategic items to the US gover...
Jan 04, 2023 (Gmt+09:00)
-
Korean Innovators at CES 2023
Seoul Viosys receives CES Display Innovation Award
Seoul Viosys Co. said on Tuesday that it received the Innovation Award in the display category for a component called "WICOP pixel" at CES 2023, the...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Remsima receives approval in 100 countries in 10 years
South Korea's most valuable biopharmaceutical company Celltrion Inc. said on Tuesday that its antibody biosimilar Remsima (ingredient: infliximab) h...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals introduces Tiglutik, treatment for Lou Gehrig's disease
SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...
Jan 02, 2023 (Gmt+09:00)
-
Electronics
Korean firms head to CES 2023 to showcase innovative technologies
LAS VEGAS, NV – A growing number of South Korea’s leading companies and startups are heading to CES 2023, the world’s largest tech...
Jan 02, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Economy
Italian envoy to Korea says what works in Korea works globally
Italian Ambassador to South Korea Federico Failla said that as both Italy and Korea cherish and prioritize the importance of tradition and innovatio...
Dec 26, 2022 (Gmt+09:00)
-
Leadership & Management
Hyundai Heavy Industries Group changes its name to HD Hyundai
HD Hyundai held a 50th-anniversary vision declaration ceremony at its Global R&D Center in Seongnam, Gyeonggi Province, on Monday where it annou...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Fintech
South Korea doubles gov't fintech innovation fund to $781 million
The South Korean government will double the value of its Fintech Innovation Fund, a source of financial support for the financial technology or fint...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)
-
Batteries
SKC to showcase innovative chip, battery materials at CES 2023
SKC Ltd., a South Korean chemical materials maker, will showcase innovative materials for rechargeable batteries and semiconductors at CES 2023, the...
Dec 25, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Energy
Hyundai Heavy Industries Group develops dual LNG-hydrogen engine
Hyundai Heavy Industries (HHI) Group has developed South Korea's first hybrid engine that uses liquefied natural gas (LNG) and hydrogen.The group's ...
Dec 23, 2022 (Gmt+09:00)
-
Rights offerings
SK Innovation to inject $1.6 bn into SK On's rights offering
South Korea's top refiner SK Innovation Co. said on Dec. 21 it will invest 2 trillion won ($1.6 billion) in its electric battery maker unit SK On Co...
Dec 22, 2022 (Gmt+09:00)
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Bigsome Bio signs tech transfer agreement with university
Bigsome Bio, a subsidiary of Lotte Chilsung Beverage, has begun research on functional materials for respiratory health.The company said on Friday t...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Batteries
Doosan obtains certification on hydrogen batteries for drones
Doosan Mobility Innovation (DMI) said on Wednesday that its hydrogen fuel cell power pack DP30M2S product, which is mounted on hydrogen-fueled drone...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Batteries
SK Innovation, SungEel HiTech form discarded battery joint venture
South Korea's SK Innovation Co. is forming a joint venture with SungEel HiTech Co., a company that recycles discarded batteries, to extract metals f...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech firm Noul signs MOU with disease center of Ghana
South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
Fintech
South Korea to boost fintech fund to 1 trillion won
South Korea's financial authorities have decided to increase the size of the Fintech Innovation Fund from 500 billion won($379 million) to 1 trillion ...
Dec 08, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ partners with Emmyon to develop ingredients preventing muscle atrophy
South Korean food giant CJ CheilJedang Corp. announced on Tuesday that it has signed a license contract with Emmyon, an American biotechnology start...
Dec 06, 2022 (Gmt+09:00)